Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (331-340 of 384) with videos related to

Pageof 39
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Tissue factor pathway inhibitor release induced by defibrotide and heparinsG Cella, A Sbarai, G Mazzaro, et al.
The Journal of Surgical Research|June 1, 1984
Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitisR Izquierdo, L Sandberg, M O Nora, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass modelJ M Walenga, M Bakhos, H L Messmore, et al.
Thrombosis Research|April 15, 1994
Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cellsM A Pinhal, J M Walenga, W Jeske, et al.
The Journal of Invasive Cardiology|November 2, 2001
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplastyE D Grassman, F Leya, J Fareed, et al.
Journal of Medicinal Chemistry|June 1, 1990
Oligosaccharide mapping of low molecular weight heparins: structure and activity differencesR J Linhardt, D Loganathan, A al-Hakim, et al.
Journal of Vascular Surgery|April 1, 1996
Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary resultsJ I Arcelus, J A Caprini, K N Hoffman, et al.
The American Journal of Cardiology|December 22, 1999
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectorisM M Rabah, J Premmereur, M Graham, et al.
Thrombosis Research|January 12, 2001
Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expressionA Scazziota, R Altman, J Rouvier, et al.
Pageof 39

Showing results (331-340 of 384) with videos related to

Sort By:
Pageof 39
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Tissue factor pathway inhibitor release induced by defibrotide and heparinsG Cella, A Sbarai, G Mazzaro, et al.
The Journal of Surgical Research|June 1, 1984
Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitisR Izquierdo, L Sandberg, M O Nora, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass modelJ M Walenga, M Bakhos, H L Messmore, et al.
Thrombosis Research|April 15, 1994
Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cellsM A Pinhal, J M Walenga, W Jeske, et al.
The Journal of Invasive Cardiology|November 2, 2001
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplastyE D Grassman, F Leya, J Fareed, et al.
Journal of Medicinal Chemistry|June 1, 1990
Oligosaccharide mapping of low molecular weight heparins: structure and activity differencesR J Linhardt, D Loganathan, A al-Hakim, et al.
Journal of Vascular Surgery|April 1, 1996
Laboratory assays and duplex scanning outcomes after symptomatic deep vein thrombosis: preliminary resultsJ I Arcelus, J A Caprini, K N Hoffman, et al.
The American Journal of Cardiology|December 22, 1999
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectorisM M Rabah, J Premmereur, M Graham, et al.
Thrombosis Research|January 12, 2001
Abciximab treatment in vitro after aspirin treatment in vivo has additive effects on platelet aggregation, ATP release, and P-selectin expressionA Scazziota, R Altman, J Rouvier, et al.
Pageof 39